Novel single molecule imaging approaches reveal structure-function alterations to the nuclear pore complex in early C9ORF72-associated TDP-43 proteinopathy

Using novel single-molecule imaging techniques, this study reveals that soluble poly(glycine-arginine) peptides from C9ORF72 mutations disrupt nuclear export and alter the structural organization of the nuclear pore complex, thereby initiating TDP-43 proteinopathy in ALS and FTD.

The Gist

The Big Picture: A Clogged Gate in the Brain's Control Center

Imagine your cells as busy cities. The Nucleus is the City Hall where the master blueprints (DNA) are kept. The Cytoplasm is the rest of the city where the work gets done. To keep the city running, blueprints and workers need to move back and forth between City Hall and the rest of the city.

The gate that controls this traffic is called the Nuclear Pore Complex (NPC). Think of it not just as a door, but as a massive, high-tech security checkpoint with three distinct zones:

1. The Cytoplasmic Filaments: The outer security fence (outside the city).
2. The Central Channel: The actual tunnel through the gate.
3. The Nuclear Basket: The inner lobby (inside City Hall).

In diseases like ALS (Lou Gehrig's disease) and FTD (Frontotemporal Dementia), this gate starts to malfunction. This paper investigates why and how this happens, specifically looking at a genetic mutation called C9ORF72.

The Villain: The "Sticky Glue" (PolyGR)

People with this specific mutation produce a toxic substance called polyGR. Imagine polyGR as a super-sticky, arginine-rich glue. This glue doesn't just stick to one thing; it sticks to the security checkpoint itself (the Nuclear Pore) and messes with the workers (proteins) trying to get through.

The Innovation: A New Way to Watch the Traffic

Before this study, scientists had to break open cells or freeze them to see how the gate worked. It was like trying to study traffic flow by taking a car apart in a garage. You couldn't see how the car actually drove on the road.

The researchers developed two new "super-eyes":

1. The "Ghost Cam" (Single Molecule Tracking): They used a special camera and a smart computer program (Deep Learning) to watch individual tiny particles (like 10kDa dextran, which is like a tiny, invisible drone) fly through the gate in living, unmodified cells. They could see exactly where the drones got stuck, how fast they moved, and which part of the gate they touched.
2. The "3D Blueprint" (Structural Imaging): They used a clever trick with standard microscopes and computer simulations to measure the exact size and shape of the gate's parts without needing expensive, specialized super-resolution microscopes.

What They Discovered: The Gate is Jamming

When they exposed the cells to the "sticky glue" (polyGR), they found some surprising things:

1. The Exit is Worse Than the Entrance
Usually, we think of things getting stuck when entering a building. But here, the glue made it much harder for things to leave the City Hall (Nuclear Export).

• The Analogy: Imagine a revolving door. The glue makes it so that people trying to exit the building get stuck in the inner lobby (Nuclear Basket) and the tunnel (Central Channel). They can't get out. However, people trying to enter are only slightly slowed down.

2. The Tunnel Shrinks, The Lobby Expands
The "Ghost Cam" showed that the traffic flow was getting narrower in the middle. The structural imaging confirmed this:

• The Central Tunnel (where the traffic passes) actually shrunk (contracted).
• The Inner Lobby (Nuclear Basket) actually expanded (got wider).
• The Analogy: It's like a hallway that suddenly gets narrower in the middle but the waiting room at the end gets bigger. This creates a bottleneck. The "sticky glue" is physically squeezing the tunnel shut while pushing the walls of the lobby outward.

3. The "TDP-43" Worker Gets Lost
There is a key protein called TDP-43 that acts like a manager in the cell. In healthy cells, it stays mostly inside City Hall. In ALS/FTD, it gets kicked out and clumps together in the city streets, causing damage.

• The study found that even after just one hour of exposure to the sticky glue, the TDP-43 manager started to leak out of City Hall.
• This suggests that the jamming of the gate is one of the very first steps that leads to the disease.

Why This Matters

This paper is a breakthrough because it didn't just guess what was happening; it watched it happen in real-time in a living cell.

• Old way: "We think the gate is broken because the room is messy."
• New way: "We watched the gate, saw the tunnel shrink, saw the traffic jam at the exit, and saw the manager get kicked out, all within minutes."

The Takeaway

The "sticky glue" (polyGR) produced by the C9ORF72 mutation physically reshapes the cell's main gate. It squeezes the tunnel and widens the lobby, causing traffic to jam, especially when trying to leave the nucleus. This jamming happens so quickly that it starts to kick out important proteins (TDP-43), setting off the chain reaction that leads to neurodegenerative diseases like ALS and FTD.

By understanding exactly how the gate breaks, scientists can now look for drugs that might stop the glue from sticking or help the gate stay open, potentially treating the disease before the damage becomes permanent.

Technical Summary

1. Problem Statement

Nucleocytoplasmic transport through the Nuclear Pore Complex (NPC) is critical for cellular homeostasis. Dysfunction in this process is a hallmark of neurodegenerative diseases, specifically Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) linked to the C9ORF72 mutation. This mutation produces toxic dipeptide repeat (DPR) polypeptides, notably poly(glycine-arginine) or polyGR, which are hypothesized to disrupt NPC structure and function, leading to the mislocalization of the RNA-binding protein TDP-43.

Current Limitations:

• Methodological Gaps: Previous studies relied on permeabilized cells or isolated nuclei, which alter NPC composition and remove cytoplasmic factors essential for transport regulation.
• Resolution Issues: Standard summative assays (measuring total nuclear vs. cytoplasmic protein levels) cannot distinguish between defects in transport dynamics, protein production, or turnover.
• Genetic Modification: Many high-resolution techniques require genetically modified cells (e.g., fluorescent protein tagging), which may artificially alter NPC structure or dynamics.
• Lack of Direct Observation: There is a lack of direct, single-molecule visualization of passive transport dynamics through specific NPC subdomains in intact, unmodified cells.

2. Methodology

The authors developed two novel, integrative approaches to overcome these limitations, utilizing the neuroblastoma cell line SH-SY5Y (intact, non-genetically modified).

A. Single-Molecule Tracking (SMT) of Passive Transport

• Imaging Technique: Combined HILO (Highly Inclined and Laminated Optical sheet) microscopy with TIRF (Total Internal Reflection Fluorescence) bleaching. HILO allowed imaging at a depth of ~2 µm (nuclear envelope level) while maintaining single-molecule sensitivity. TIRF was used to bleach background noise near the coverslip.
• Cargo: A small, inert, receptor-independent cargo: 10 kDa CF640R-tagged dextran.
• Deep Learning Integration: To avoid genetic modification of the nuclear envelope, a 2D FNet deep learning model was trained on paired brightfield and mCherry-LaminB1 fluorescence images. This model predicted the nuclear envelope (NE) position from brightfield images alone, allowing for precise mapping of transport tracks relative to the NE.
• Data Processing:
  • Denoising using CANDLE (Collaborative Approach for Enhanced Denoising under Low-light Excitation).
  • Track analysis using nearest-neighbor algorithms.
  • Tracks were mapped onto a theoretical NPC domain model (Cytoplasmic Filaments, Central Channel, Nuclear Basket) to analyze directionality (Import vs. Export) and subdomain interactions.

B. Paired Localisation and Diameter Simulation for NPC Structure

• Immunostaining: Used dye-conjugated antibodies against Nup98 (central domain marker) and Nup50 (nuclear basket marker) on fixed cells.
• Super-Resolution Imaging: Utilized angled-beam imaging (7°–8° tilt) to improve signal-to-noise ratio and reduce background.
• Simulation Modeling:
  • Single-molecule localizations of Nup98 and Nup50 were aligned.
  • A simulation approach generated ~120,000 random spot distributions to find the "best-fit" model matching experimental inter-spot distances.
  • Structural Similarity Index (SSIM) was used to validate the fidelity between the model and experimental data, allowing the calculation of effective diameters for NPC subdomains.

3. Key Contributions

1. Novel Methodology: Established the first method for single-molecule tracking of passive nucleocytoplasmic transport in intact, non-genetically modified cells with sub-domain resolution.
2. Deep Learning Application: Successfully applied deep learning to predict nuclear envelope positions from brightfield images, eliminating the need for fluorescent protein tags that could perturb native dynamics.
3. Structural-Functional Correlation: Developed a workflow combining conventional immunostaining with simulation to resolve the ring-based structural organization of endogenous NPC components without specialized super-resolution hardware.
4. Disease Mechanism Insight: Directly linked acute exposure to C9ORF72-derived polyGR to specific structural and functional alterations in the NPC and early TDP-43 pathology.

4. Key Results

A. Baseline Transport Dynamics

• In untreated cells, passive transport (10 kDa dextran) showed distinct dynamics for Import vs. Export.
• Success Rates: Export success (36.7%) was higher than import (29.8%).
• Dynamics: Molecules moved at ~1.9–2.7 µm/s. Import showed higher dynamics in the nuclear basket, while export showed higher dynamics in cytoplasmic filaments.

B. Impact of PolyGR on Transport (Functional)

• Directional Bias: PolyGR exposure (1–10 µM, 1 hr) disrupted transport significantly more in nuclear export than import.
• Density Shifts:
  • Export: Significant reduction in molecular density in the nuclear basket (up to 8.6% decrease) and accumulation in the central channel (up to 11.0% increase).
  • Import: Minor changes, primarily a slight reduction in cytoplasmic filament interaction.
• Kinetics: PolyGR caused a ~10% decrease in molecular velocity and acceleration across subdomains.
• Success Rate: Passive export success dropped by 19.1% at 10 µM polyGR, compared to an 8.1% drop in import.
• Paradox: Despite reduced export dynamics, summative analysis showed nuclear accumulation of the cargo. This is attributed to polyGR-induced retention of cargo within nuclear structures (e.g., nucleolus) rather than a simple blockage of the pore.

C. Impact of PolyGR on NPC Structure

• Nup98 (Central Domain): Diameter contracted from 95 nm (control) to 86 nm (polyGR). This correlates with the observed narrowing of the central channel and increased molecular density there.
• Nup50 (Nuclear Basket): Diameter expanded from 60 nm (control) to 71 nm (polyGR). This correlates with reduced molecular interaction/dwell time in the nuclear basket during export.
• Conclusion: PolyGR induces a structural rearrangement where the central pore constricts and the nuclear basket expands.

D. TDP-43 Mislocalization

• Acute polyGR exposure (10 µM, 1 hr) resulted in a 16.0% reduction in the nuclear-to-cytoplasmic ratio of TDP-43.
• This indicates that structural and functional NPC defects precede and likely initiate the cytoplasmic mislocalization of TDP-43, a key pathological hallmark of ALS/FTD.

5. Significance

• Mechanistic Link: The study provides the first direct evidence that C9ORF72-associated polyGR peptides initiate disease pathology by physically altering NPC architecture (constriction of the central pore, expansion of the basket), which in turn disrupts passive transport dynamics (specifically export) and triggers TDP-43 mislocalization.
• Methodological Advance: The developed techniques offer a powerful, non-invasive toolkit for studying nucleocytoplasmic transport in physiological conditions, applicable to other neurodegenerative diseases and drug screening.
• Therapeutic Implications: By identifying that polyGR specifically targets the central pore and nuclear basket, potential therapeutic strategies could focus on stabilizing these specific NPC subdomains to restore transport homeostasis before irreversible protein aggregation occurs.

In summary, this paper bridges the gap between molecular structure and cellular function in neurodegeneration, demonstrating that toxic DPRs cause early, specific structural deformations in the NPC that disrupt transport kinetics and initiate TDP-43 pathology.